US Stock MarketDetailed Quotes
CRVO CervoMed
- 17.040
- +2.040+13.60%
Close Aug 14 16:00 ET
- 17.040
- 0.0000.00%
Post 20:01 ET
140.64MMarket Cap-44490P/E (TTM)
17.940High15.000Low99.48KVolume15.300Open15.000Pre Close1.66MTurnover2.63%Turnover RatioLossP/E (Static)8.25MShares26.37952wk High2.81P/B64.58MFloat Cap4.28052wk Low--Dividend TTM3.79MShs Float3375000000.000Historical High--Div YieldTTM19.60%Amplitude4.140Historical Low16.729Avg Price1Lot Size
CervoMed Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.22%-2.2M | 3.93%-1.42M | -189.57%-7.45M | -266.55%-2.54M | -121.40%-1.47M | 51.04%-1.96M | 68.67%-1.48M | 82.26%-2.57M | 77.11%-692.53K | 330.67%6.86M |
| Net income from continuing operations | -62.53%-2.32M | -370.55%-2.51M | 62.57%-2.17M | -54.67%-2.36M | -51.58%2.15M | 65.98%-1.43M | 88.20%-534.34K | 75.92%-5.8M | 56.04%-1.53M | 136.41%4.44M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.53%127.52K | --0 | ---- |
| Change In working capital | 84.57%-125.11K | 642.41%872.45K | -168.79%-261.36K | -354.72%-341.03K | 35.32%1.05M | -1,188.10%-810.6K | 65.61%-160.85K | 6.61%379.94K | 14.67%133.88K | -8.43%776.74K |
| -Change in receivables | --0 | --915.4K | ---915.4K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in prepaid assets | 5.07%-912.07K | 81.53%-116.33K | -1,510.21%-1.2M | 1,422.06%348.92K | -81.93%41.48K | -354.27%-960.82K | -26.98%-629.71K | 134.18%85.1K | 79.69%-26.39K | 33.45%229.52K |
| -Change in payables and accrued expense | 55.91%-42.07K | -182.49%-499.1K | 528.90%1.85M | 381.99%772.51K | 4.54%572.05K | 78.35%-95.43K | 2,049.73%605.06K | -51.30%294.83K | -35.02%160.27K | -19.08%547.22K |
| -Change in other working capital | 237.48%829.03K | 520.33%572.48K | ---- | ---- | --437.6K | --245.65K | ---136.2K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.22%-2.2M | 3.93%-1.42M | -189.57%-7.45M | -266.55%-2.54M | -121.40%-1.47M | 51.04%-1.96M | 68.67%-1.48M | 82.26%-2.57M | 77.11%-692.53K | 330.67%6.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11.15M | -93.38K | 224,949.78%11.24M | 0 | 0 | -5K | ||||
| Net common stock issuance | ---- | ---- | --810K | --0 | --810K | ---- | ---- | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | --10.34M | ---93.38K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | --11.15M | ---93.38K | 224,949.78%11.24M | ---- | ---- | --0 | --0 | ---5K |
| Net cash flow | ||||||||||
| Beginning cash position | 143.88%6.37M | 90.37%7.79M | -38.59%4.09M | 117.81%10.42M | -89.11%649.78K | -73.55%2.61M | -89.03%4.09M | -64.00%6.67M | -88.13%4.79M | -86.22%5.97M |
| Current changes in cash | 285.54%3.64M | 3.93%-1.42M | 243.79%3.7M | -280.03%-2.63M | -66.83%9.77M | 49.78%-1.96M | 94.60%-1.48M | -113.69%-2.57M | 77.08%-692.53K | 1,091.33%29.47M |
| End cash Position | 1,440.39%10.01M | 143.88%6.37M | 90.37%7.79M | 90.37%7.79M | 117.81%10.42M | -89.11%649.78K | -73.55%2.61M | -89.03%4.09M | -89.03%4.09M | -88.13%4.79M |
| Free cash flow | -12.22%-2.2M | 3.93%-1.42M | -189.57%-7.45M | -266.55%-2.54M | -121.40%-1.47M | 51.04%-1.96M | 68.67%-1.48M | 82.26%-2.57M | 77.11%-692.53K | 330.67%6.86M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
